Angiotensin Receptor Antagonists: all 1,100 studies that test it

Page 6 of 11. Open to participants first (75), then studies with results posted, then the rest; newest registration first within each.

• The Effects of Neprilysin on Glucagon-like Peptide-1CompletedNCT03717688Phase 4
• The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Adult Volunteers VolunteersCompletedNCT03707899Phase 1
• Bioequivalence Study of Two Formulations of Telmisartan 80 mg Tablets in Healthy Adult Volunteers Under Fasting StateCompletedNCT03705533Phase 1
• Nighttime Losartan in Continous Ambulatory Peritoneal Dialysis (NVCAPD)Status unknownNCT03692013Phase 4
• Candesartan in Peripheral NeuropathyTerminatedNCT03688633Phase 2
• Randomized Evaluation of Beta Blocker and ACEI/ARB Treatment in MINOCA Patients - MINOCA-BATTerminatedNCT03686696Phase 4
• Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes PatientsWithdrawnNCT03686657Phase 1/2
• Clinical Trial to Compare the Safety and Pharmacokinetics of YH22162 in Healthy VolunteersCompletedNCT03662620Phase 1
• Effect of Olmesartan and Nebivolol on Ambulatory Blood Pressure and Arterial Stiffness in Acute Stage of Ischemic StrokeCompletedNCT03655964Phase 2
• Bioequivalence Study of Azilsartan Tablets in Chinese Healthy VolunteersCompletedNCT03652792Phase 1
• Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=27)CompletedNCT03648333Phase 1
• Evaluation of Losartan on Cardiovascular Disease in Patients With Mucopolysaccharidoses IV A and VIStatus unknownNCT03632213Phase 2
• Losartan/Amlodipine on Hemodynamics Parameters and Arterial Stiffness in Arterial HypertensionStatus unknownNCT03626259Phase 4
• Nighttime Valsartan in Hemodialysis HypertensionStatus unknownNCT03594825Phase 4
• Adiposity and Endothelin Receptor FunctionActive, not recruitingNCT03583866Early Phase 1
• Fixed-Free HTN TrialStatus unknownNCT03578042Phase 4
• Efficacy/Safety of Telmisartan/Amlodipine/Rosuvastatin in Hypertensive Patients With HyperlipidemiaCompletedNCT03566316Phase 3
• Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic CancerActive, not recruitingNCT03563248Phase 2
• Use of Impedance Cardiography and Applanation Tonometry for Prediction of the Antihypertensive Effect of Two DrugsCompletedNCT03560804Not applicable
• Role of ARNi in Ventricular Remodeling in Hypertensive LVHCompletedNCT03553810Phase 2
• Pharmacodynamic Effects of Sacubitril/Valsartan on Natriuretic Peptides, Angiotensin and NeprilysinStatus unknownNCT03553303Phase 4
• Evaluating a Pharmacokinetic Drug Interaction Between LGEV1801 and LGEV1802CompletedNCT03532854Phase 1
• Angiotensin-II Receptor Antibodies Blockade With Losartan in Patients With Lupus NephritisStatus unknownNCT03526042Not applicable
• Glucagon-like Peptide-1 Metabolism and Acute Neprilysin InhibitionWithdrawnNCT03508739Phase 3
• Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2)WithdrawnNCT03504566Phase 4
• Antihypertensive Pharmacological Therapy With Mineralocorticoid Receptor Antagonists in Obese Hypertensive PatientsCompletedNCT03476616Phase 4
• Drug-drug Interaction Following Oral Administration of Telmisartan/Amlodipine and Atorvastatin in Healthy Adult VolunteersCompletedNCT03461081Phase 1
• A Bioequivalence Study of Losartan Potassium Tablets (Containing Losartan Potassium 100 mg) in Normal, Healthy, Adults Under Fasting ConditionsCompletedNCT03459911Phase 1
• Phase I Drug-drug Interaction of Omega-3 and AtorvastatinStatus unknownNCT03438955Phase 1
• Effect of Losartan in Cystic Fibrosis (CF)-NIH Grant #133240CompletedNCT03435939Early Phase 1
• The Effect of Losartan on Emotional Processing in Healthy VolunteersCompletedNCT03434054Not applicable
• Effect of Fully Blocking Type 1 Angiotensin Receptor on Target Organ Damage of Postmenopausal Hypertensive WomenStatus unknownNCT03432468Not applicable
• Influences of Angiotensin-neprilysin Inhibition on Sympathetic Activity in Heart FailureWithdrawnNCT03415906Phase 2
• Losartan and Emotion ProcessingStatus unknownNCT03396523Not applicable
• Beginning of Effective and Safe Treatment in Immunoglobulin A-1 Nephropathy-1Status unknownNCT03357653Phase 3
• A Study to Evaluate the Efficacy and Safety of Combination Treatment of Fimasartan/Atorvastatin in Patients With Essential Hypertension and DyslipidemiaCompletedNCT03338426Phase 3
• AT1R Blockade and Periodic Breathing During Sleep in HypoxiaCompletedNCT03335904Phase 4
• Efficacy of Angiotensin Receptor Blocker Following aortIc Valve Intervention for Aortic STenOsis: a Randomized mulTi-cEntric Double-blind Phase II StudyWithdrawnNCT03315832Phase 2/3
• Fimasartan Plus Amlodipine on Hemodynamic Parameters and Arterial Stiffness in Patients With HypertensionStatus unknownNCT03294070Phase 4
• Sacubitril-valsartan Versus Usual Anti-hypertensives in LVADWithdrawnNCT03279861Phase 4
• A Study on Molecular Genetics of Drug Responsiveness in Essential HypertensionCompletedNCT03276598Phase 4
• The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Male Volunteers VolunteersCompletedNCT03247140Phase 1
• Evaluate the Efficacy and Safety of Combination Treatment With DW1501-R1+DW1501-R2 Versus DW1501-R1 or DW1501-R2+DW1501-R3 in Patients With Hypertension and DyslipidemiaCompletedNCT03210532Phase 3
• Efficacy and Safety of Valsartan and Nebivolol/Valsartan in Hypertensive Patients With LVHCompletedNCT03180593Phase 4
• Combination of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and DyslipidemiaCompletedNCT03156842Phase 3
• Clinical Study of Treating Type 2 Diabetic Nephropathy With Alfacalcidol and IrbesartanCompletedNCT03147677Phase 4
• Matão Controlling Hypertension (MatCH Study): Rationale and DesignStatus unknownNCT03147092Early Phase 1
• Comparing ARNI With ACE Inhibitor on Endothelial FunctionWithdrawnNCT03119623Phase 4
• Mechanism(s) Underlying Cardiovascular Effects of ARB/NEP Inhibition - Aim 2WithdrawnNCT03005184Phase 2
• Efficacy of Olmesartan on Cerebral Glucose Metabolism, Vascular Inflammation and Adipose TissueStatus unknownNCT02996916Phase 4
• A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Atorvastatin in Healthy Male Volunteers.CompletedNCT02994745Phase 1
• Bioequivalence Study (Candesartan 16 mg and Amlodipine 10 mg)CompletedNCT02988362Phase 1
• Amlodipine Versus Valsartan for Improvement of Diastolic Dysfunction Associated With HypertensionCompletedNCT02973035Phase 4
• A Clinical Trial of YMC017 in Hypertensive and Hypercholesterolemic Patients With Metabolic SyndromeTerminatedNCT02968160Phase 4
• Comparison of Blood Pressure Lowering Effect Between Fimasartan and LosartanStatus unknownNCT02958631Phase 4
• Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential HypertensionCompletedNCT02944734Phase 2
• Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male VolunteersCompletedNCT02933658Phase 1
• A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Fimasartan and Amlodipine in Healthy Male SubjectsCompletedNCT02920047Phase 1
• Risk Reduction for Alzheimer's DiseaseCompletedNCT02913664Phase 2/3
• Strategies to Promote Cessation in Smokers Who Are Not Ready To QuitCompletedNCT02905656Not applicable
• Antihypertensive Treatment in Masked HypertensionCompletedNCT02893358Phase 4
• Expression and Function of the Renin-Angiotensin System in the EsophagusCompletedNCT02879721Early Phase 1
• Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and HypertensionCompletedNCT02842359Phase 4
• The DDI Study of SP2086 and ValsartanStatus unknownNCT02817217Phase 1
• The Drug-drug Interaction of SP2086 and ValsartanCompletedNCT02815657Phase 1
• Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - BCompletedNCT02811731Phase 1
• Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - ACompletedNCT02801526Phase 1
• Evaluation of the Entresto Effect on Sympathic Nervous System in Patient With Heart FailureTerminatedNCT02787798Phase 4
• Pharmacokinetics Study of Azilsartan Tablets in Chinese Healthy VolunteersCompletedNCT02786082Phase 1
• The Precision Hypertension Care StudyCompletedNCT02774460Phase 4
• Pilot Trial: the Safety and Feasibility of Losartan for Pulmonary Vein StenosisSuspendedNCT02769130Phase 1/2
• N-of-1 Trials for Blood Pressure Medications in AdultsCompletedNCT02744456Early Phase 1
• Efficacy and Safety of TAH Combination in Comparison With Telmisartan/Amlodipine Combination for Essential Hypertension PatientsCompletedNCT02738632Phase 3
• Clinical Trial to Compare the Pharmacokinetics of DP-R208CompletedNCT02707224Phase 1
• Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts TrialCompletedNCT02699645Phase 3
• Pharmacological Reduction of Functional, Ischemic Mitral REgurgitationCompletedNCT02687932Phase 4
• Randomized Clinical Trial of Intravitreal Bevacizumab Versus Intravitreal Bevacizumab Combined With Losartan in the Treatment of Diabetic Macular EdemaCompletedNCT02663141Phase 2
• Fixed-dose Combination of Valsartan + Rosuvastatin Versus Their Isolated Components for Hypertension and Dyslipidemia.WithdrawnNCT02662894Phase 3
• Chronopharmacology of Valsartan in Normotensive SubjectsCompletedNCT02631031Phase 1
• Investigate a Interaction of Candesartan and Atorvastatin in Healthy Male SugjectsStatus unknownNCT02609711Phase 1
• Azilsartan in Chinese Patients With Mild and Moderate HypertensionCompletedNCT02609490Phase 3
• Angiotensin II Receptor Blockade in Vascular Ehlers Danlos Syndrome (ARCADE)CompletedNCT02597361Phase 3
• To Evaluate the Drug-drug Interaction Between Telmisartan and Atorvastatin in Healthy Male VolunteersCompletedNCT02579356Phase 1
• Physiologic Interactions Between the Adrenal- and the Parathyroid GlandsCompletedNCT02572960Phase 4
• A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/RosuvastatinCompletedNCT02569814Phase 1
• A Study to Compare the Pharmacokinetics of Fimasartan/Atorvastatin Combination TabletCompletedNCT02566187Phase 1
• Efficacy and Safety of Candesartan Associated With Chlorthalidone Versus Losartan Associated With Hydrochlorothiazide (Hyzaar®) in Essential Hypertension ControlWithdrawnNCT02521246Phase 3
• Efficacy and Safety of Candesartan Associated With Chlorthalidone in Essential Arterial Hypertension ControlWithdrawnNCT02521233Phase 3
• A Bioequivalence Study of Amlodipine / Valsartan From Amlodipine/Valsartan 10/160 Tablets (Pharmacare, Palestine) and Exforge Tablets (Novartis Pharma, USA)CompletedNCT02519010Phase 1
• Bioequivalence Evaluation of Two Film-Coated Formulations of Valsartan 160 mgCompletedNCT02518451Not applicable
• The Effect of Rosuvastatin and Olmesartan on the Progression of Coronary Atherosclerotic DiseaseStatus unknownNCT02516826Phase 2
• Fimasartan Achieving SBP Target (FAST) StudyCompletedNCT02495324Phase 4
• Efficacy and Safety of Olmesartan Associated With Chlorthalidone in Essential Arterial Hypertension ControlWithdrawnNCT02493322Phase 3
• Efficacy and Safety of Olmesartan Associated With Chlorthalidone Versus Benicar HCT® in Essential Hypertension ControlWithdrawnNCT02483936Phase 3
• Efficacy and Safety of Fimasartan Alone or Combined With HCTZ in Mexican Patients With Essential HypertensionCompletedNCT02466490Phase 3
• Efficacy and Safety of Azilsartan Compared to Olmesartan Medoxomil in Chinese Participants With Grade I or II Essential HypertensionStatus unknownNCT02407210Phase 3
• Comparison of Peripheral and Cerebral Arterial Flow in Acute Ischemic Stroke: Fimasartan vs. Valsartan vs. AtenololStatus unknownNCT02403349Phase 4
• A Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia.WithdrawnNCT02400775Phase 4
• Study to Evaluate the Pharmacokinetic Interaction Between Fimasartan and Atorvastatin in Healthy Male VolunteersCompletedNCT02397590Phase 1
• Study to Evaluate the Pharmacokinetic Interaction and Safety After Multiple Oral Doses of Fimasartan/Amlodipine and Rosuvastatin in Healthy Male SubjectsCompletedNCT02397538Phase 1

← Angiotensin Receptor Antagonists overview